BIOMAT Database Logo BIOMAT Database Logo

Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders. 2006

Ramesh Rengan, and Philip B Paty, and W Douglas Wong, and Jose G Guillem, and Martin Weiser, and Larissa Temple, and Leonard Saltz, and Bruce D Minsky
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

BACKGROUND The primary objective of this study was to determine the long-term outcome of sphincter preservation with preoperative radiation therapy (RT) and surgical resection in the treatment of distal rectal adenocarcinoma. METHODS Between April 1988 and December 1996, 36 (cT2, n=9; cT3, n=27) patients with rectal adenocarcinoma were enrolled on a phase I/II trial of preoperative RT followed by surgical resection. All patients had distal tumors that were clinically judged to require an abdominoperineal resection and received preoperative RT (50.4 Gy) followed by surgery. The median follow-up was 94.5 months (range, 4-187 months). RESULTS Of the 35 patients in this study who underwent resection, 77% were able to undergo sphincter preservation after preoperative RT. The pathologic complete response rate for these patients was 14%. The 10-year rates of overall survival and local failure for patients undergoing sphincter preservation were 54% and 21%, respectively. The 10-year local failure was 26% in patients with cT3 disease who underwent sphincter preservation. All local failures in this study occurred in patients with cT3 disease undergoing sphincter preservation; however, none of the patients with cT3 disease that was downstaged by preoperative RT experienced local failure. In contrast, 10-year local failure was 67% in the patients with cT3 disease that was not downstaged by RT. Sphincter function was good or excellent in 85% of patients at the time of last follow-up. CONCLUSIONS This approach provides excellent long-term results in all patients with cT2 disease and those with cT3 disease that is downstaged by RT. However, patients with cT3 disease that is not downstaged by RT have an increased risk of local failure. These data underscore the impact of tumor response to radiation on long-term oncologic outcome.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Ramesh Rengan, and Philip B Paty, and W Douglas Wong, and Jose G Guillem, and Martin Weiser, and Larissa Temple, and Leonard Saltz, and Bruce D Minsky
Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by local excision.
January 1998, Seminars in radiation oncology,
Ramesh Rengan, and Philip B Paty, and W Douglas Wong, and Jose G Guillem, and Martin Weiser, and Larissa Temple, and Leonard Saltz, and Bruce D Minsky
Sphincter preservation in rectal cancer. Local excision followed by postoperative radiation therapy.
January 1998, Seminars in radiation oncology,
Ramesh Rengan, and Philip B Paty, and W Douglas Wong, and Jose G Guillem, and Martin Weiser, and Larissa Temple, and Leonard Saltz, and Bruce D Minsky
Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by low anterior resection with coloanal anastomosis.
January 1998, Seminars in radiation oncology,
Ramesh Rengan, and Philip B Paty, and W Douglas Wong, and Jose G Guillem, and Martin Weiser, and Larissa Temple, and Leonard Saltz, and Bruce D Minsky
Sphincter preservation in rectal cancer by local excision and postoperative radiation therapy.
February 1991, Cancer,
Ramesh Rengan, and Philip B Paty, and W Douglas Wong, and Jose G Guillem, and Martin Weiser, and Larissa Temple, and Leonard Saltz, and Bruce D Minsky
Results of local excision followed by postoperative radiation therapy for rectal cancer.
January 1997, Radiation oncology investigations,
Ramesh Rengan, and Philip B Paty, and W Douglas Wong, and Jose G Guillem, and Martin Weiser, and Larissa Temple, and Leonard Saltz, and Bruce D Minsky
High dose preoperative radiation and sphincter preservation in the treatment of rectal cancer.
June 1987, International journal of radiation oncology, biology, physics,
Ramesh Rengan, and Philip B Paty, and W Douglas Wong, and Jose G Guillem, and Martin Weiser, and Larissa Temple, and Leonard Saltz, and Bruce D Minsky
Sphincter preservation in rectal cancer. Endocavitary radiation therapy.
January 1998, Seminars in radiation oncology,
Ramesh Rengan, and Philip B Paty, and W Douglas Wong, and Jose G Guillem, and Martin Weiser, and Larissa Temple, and Leonard Saltz, and Bruce D Minsky
Sphincter preservation in rectal cancer. Surgical considerations for local excision.
January 1998, Seminars in radiation oncology,
Ramesh Rengan, and Philip B Paty, and W Douglas Wong, and Jose G Guillem, and Martin Weiser, and Larissa Temple, and Leonard Saltz, and Bruce D Minsky
Preoperative radiation therapy and sphincter preservation by the combined abdominotranssacral technique for selected rectal cancers.
August 1985, Diseases of the colon and rectum,
Ramesh Rengan, and Philip B Paty, and W Douglas Wong, and Jose G Guillem, and Martin Weiser, and Larissa Temple, and Leonard Saltz, and Bruce D Minsky
Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapy.
October 2014, Radiation oncology (London, England),
Copied contents to your clipboard!